These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3968464)

  • 21. Assessmrent of iron overload in thalassaemic patients by magnetic resonance imaging: a pilot study.
    Kumar P; Jagannathan NR; Choudhry VP
    J Indian Med Assoc; 2007 Oct; 105(10):561-4, 591. PubMed ID: 18383951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-thalassemia and pulmonary function.
    Piatti G; Allegra L; Ambrosetti U; Cappellini MD; Turati F; Fiorelli G
    Haematologica; 1999 Sep; 84(9):804-8. PubMed ID: 10477453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum ferritin concentrations in transfusion dependent beta-thalassaemia.
    George E; Wong HB; George R; Ariffin WA
    Singapore Med J; 1994 Feb; 35(1):62-4. PubMed ID: 8009283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
    Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients.
    Dehshal MH; Hooghooghi AH; Kebryaeezadeh A; Kheirabadi M; Kazemi S; Nasseh A; Shariftabrizi A; Pasalar P
    Med Sci Monit; 2007 May; 13(5):CR235-9. PubMed ID: 17476196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive assessment of skin iron content in hemodialysis patients. An index of parenchymal tissue iron content?
    Friedlaender MM; Kaufman B; Rubinger D; Moreb J; Popovtzer MM; Goredetsky R
    Am J Kidney Dis; 1988 Jul; 12(1):18-25. PubMed ID: 3389350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spleen iron content is low in thalassemia.
    Borgna-Pignatti C; De Stefano P; Bongo IG; Avato F; Cazzola M
    Am J Pediatr Hematol Oncol; 1984; 6(3):340-3. PubMed ID: 6517228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidant micronutrients in children with thalassaemia in Egypt.
    Nasr MR; Ali S; Shaker M; Elgabry E
    East Mediterr Health J; 2002; 8(4-5):490-5. PubMed ID: 15603029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron, copper, zinc and selenium in human liver tissue measured by X-ray fluorescence spectrometry.
    Milman N; Laursen J; Pødenphant J; Staun-Olsen P
    Scand J Clin Lab Invest; 1983 Dec; 43(8):691-7. PubMed ID: 6665517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.
    Taher A; Musallam KM; El Rassi F; Duca L; Inati A; Koussa S; Cappellini MD
    Br J Haematol; 2009 Sep; 146(5):569-72. PubMed ID: 19604239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between growth disorders and iron overload in children with beta-thalassemia major].
    Huang YL; Liu S; Xia T; Hao WG; Liang W; Sun X
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):603-6. PubMed ID: 18947480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance.
    Nielsen P; Günther U; Dürken M; Fischer R; Düllmann J
    J Lab Clin Med; 2000 May; 135(5):413-8. PubMed ID: 10811057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular accident in beta-thalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI).
    Karimi M; Khanlari M; Rachmilewitz EA
    Am J Hematol; 2008 Jan; 83(1):77-9. PubMed ID: 17696211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive in-vivo measurement of hepatic and cardiac iron.
    Wielopolski L; Zaino EC
    J Nucl Med; 1992 Jul; 33(7):1278-82. PubMed ID: 1613565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Internal distribution of excess iron and sources of serum ferritin in patients with thalassemia.
    Cazzola M; Borgna-Pignatti C; de Stefano P; Bergamaschi G; Bongo IG; Dezza L; Avato F
    Scand J Haematol; 1983 Apr; 30(4):289-96. PubMed ID: 6857145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron absorption in the thalassemia syndromes and its inhibition by tea.
    de Alarcon PA; Donovan ME; Forbes GB; Landaw SA; Stockman JA
    N Engl J Med; 1979 Jan; 300(1):5-8. PubMed ID: 758174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Osteoarthropathy in beta-thalassemia].
    Musaev SK; Iakovleva GI; Nasonova VA; Smirnov AV; Abasov ESh; Efendieva EG
    Ter Arkh; 1991; 63(5):56-62. PubMed ID: 1887421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elements in muscle measured in vivo and in vitro with X-ray spectrometry.
    Yarom R; Havivi Y; Notowitz L; Friedman M; Gorodetsky R; Zeimer R
    Muscle Nerve; 1978; 1(6):486-94. PubMed ID: 757871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.